The relative proximity of Cby1-encoding gene C22orf2 (22q12) to the BCR breakpoint (22q11) suggests its BCR-ABL1-associated deletion as a putative component of beta catenin activation in CML cells (Figure 1A). Here, CTNNB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.